The HCPLive rheumatoid arthritis page is a comprehensive resource for clinical news and insights on arthritis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for RA, and more.
November 21st 2024
Data from 2 studies presented at ACR 2024 demonstrate the potential of AI to improve access to quality rheumatological assessments.
Early Rheumatoid Arthritis May Benefit from Disappearance of Anti-Citrullinated Peptide Antibodies
For early rheumatoid arthritis, the disappearance of particular anti-citrullinated peptide antibodies (ACPA) may be beneficial, according to findings published in Annals of the Rheumatic Diseases.
Bone Mineral Density Loss is Not Significantly Different Among Pre and Postmenopausal Women
There is no difference in bone mineral density loss among pre- and postmenopausal women with rheumatoid arthritis, according to research from the Babol University of Medical Sciences in Iran.
Group Therapy Shows Benefits for Rheumatoid Arthritis Patients
A support group developed by a hospital in New York has shown that patients with rheumatoid arthritis can see their condition improve by not only addressing the physical symptoms but the psychological issues as well.
Women with Rheumatoid Arthritis at Greater Risk of Dying from Respiratory Disease
Women with rheumatoid arthritis are at greater risk for respiratory-related death than women without the disease, according to data presented at the 2014 American College of Rheumatology Annual Meeting.
Zoster Vaccination in Patients with Rheumatoid Arthritis: Time to Change the Recommendation?
November 19th 2014Administration of the varicella zoster vaccine is safe in patients with rheumatoid arthritis or other rheumatic conditions who are taking biologic disease-modifying anti-rheumatic drugs, according to study results presented at the 2014 American College of Rheumatology annual meeting.
Hydroxychloroquine Reduces Risk of Cardiovascular Events in Rheumatoid Arthritis
November 18th 2014The anti-arthritis drug hydroxychloroquine dramatically reduces the risk of cardiovascular morbidity and mortality in the disease, according to research presented here at the 2014 meeting of the American College of Rheumatology.